Comparative structural and biochemical analyses of full-length ASXL1 and truncated cancer-associated ASXL1 mutations could shed light on their functional consequences and the molecular mechanisms underlying ASXL1 mutations in MDS and AML. Here, ASXL1 is linked to acute myeloid leukemia.